These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 33735532)

  • 1. Red blood cell distribution width in patients undergoing transcatheter aortic valve implantation: Implications for outcomes.
    Valenti AC; Vitolo M; Manicardi M; Arrotti S; Magnavacchi P; Gabbieri D; Tondi S; Guiducci V; Losi L; Vignali L; Sgura FA; Boriani G
    Int J Clin Pract; 2021 Jun; 75(6):e14153. PubMed ID: 33735532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Red blood cell distribution width as a prognostic factor in patients undergoing transcatheter aortic valve implantation.
    Szekely Y; Finkelstein A; Bazan S; Halkin A; Abbas Younis M; Erez J; Keren G; Banai S; Arbel Y
    J Cardiol; 2019 Sep; 74(3):212-216. PubMed ID: 31060955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red cell distribution width improves the prediction of prognosis after transcatheter aortic valve implantation.
    Collas VM; Paelinck BP; Rodrigus IE; Vrints CJ; Van Craenenbroeck EM; Bosmans JM
    Eur J Cardiothorac Surg; 2016 Feb; 49(2):471-7. PubMed ID: 25913826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raised red cell distribution width as a prognostic marker in aortic valve replacement surgery.
    Duchnowski P; Szymański P; Orłowska-Baranowska E; Kuśmierczyk M; Hryniewiecki T
    Kardiol Pol; 2016; 74(6):547-52. PubMed ID: 26502945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive rise in red cell distribution width is associated with poor outcome after transcatheter aortic valve implantation.
    Aung N; Dworakowski R; Byrne J; Alcock E; Deshpande R; Rajagopal K; Brickham B; Monaghan MJ; Okonko DO; Wendler O; Maccarthy PA
    Heart; 2013 Sep; 99(17):1261-6. PubMed ID: 23735935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1-Year Clinical Outcomes in Women After Transcatheter Aortic Valve Replacement: Results From the First WIN-TAVI Registry.
    Chieffo A; Petronio AS; Mehilli J; Chandrasekhar J; Sartori S; Lefèvre T; Presbitero P; Capranzano P; Tchetche D; Iadanza A; Sardella G; Van Mieghem NM; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail G; Sharma S; Ferrer MC; Naber C; Kievit P; Baber U; Snyder C; Sharma M; Morice MC; Mehran R;
    JACC Cardiovasc Interv; 2018 Jan; 11(1):1-12. PubMed ID: 29301640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of body mass index on the outcome of elderly patients treated with transcatheter aortic valve implantation.
    Sgura FA; Arrotti S; Monopoli D; Valenti AC; Vitolo M; Magnavacchi P; Tondi S; Gabbieri D; Guiducci V; Benatti G; Vignali L; Rossi R; Boriani G
    Intern Emerg Med; 2022 Mar; 17(2):369-376. PubMed ID: 34302612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Acute Kidney Injury on Short- and Long-term Outcomes After Transcatheter Aortic Valve Implantation.
    Nunes Filho ACB; Katz M; Campos CM; Carvalho LA; Siqueira DA; Tumelero RT; Portella ALF; Esteves V; Perin MA; Sarmento-Leite R; Lemos Neto PA; Tarasoutchi F; Bezerra HG; de Brito FS
    Rev Esp Cardiol (Engl Ed); 2019 Jan; 72(1):21-29. PubMed ID: 29358043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-year follow-up after transcatheter aortic valve implantation for symptomatic aortic stenosis.
    Zahn R; Werner N; Gerckens U; Linke A; Sievert H; Kahlert P; Hambrecht R; Sack S; Abdel-Wahab M; Hoffmann E; Zeymer U; Schneider S;
    Heart; 2017 Dec; 103(24):1970-1976. PubMed ID: 28684438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of chronic kidney disease in women undergoing transcatheter aortic valve replacement: Analysis from the Women's INternational Transcatheter Aortic Valve Implantation (WIN-TAVI) registry.
    Bandyopadhyay D; Sartori S; Baber U; Cao D; Chandiramani R; Tchétché D; Petronio AS; Mehilli J; Lefèvre T; Presbitero P; Capranzaro P; Sardella G; Van Mieghem NM; Chandrasekhar J; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail GW; Naber C; Kini A; Morice MC; Claessen BE; Chieffo A; Mehran R
    Catheter Cardiovasc Interv; 2020 Jul; 96(1):198-207. PubMed ID: 31977142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of Red Blood Cell Distribution Width in Transcatheter Aortic Valve Replacement Patients.
    Aalaei-Andabili SH; Anderson RD; Bavry AA; Barr B; Arnaoutakis GJ; Beaver TM
    Innovations (Phila); 2021; 16(6):517-522. PubMed ID: 34488482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute and 30-Day Outcomes in Women After TAVR: Results From the WIN-TAVI (Women's INternational Transcatheter Aortic Valve Implantation) Real-World Registry.
    Chieffo A; Petronio AS; Mehilli J; Chandrasekhar J; Sartori S; Lefèvre T; Presbitero P; Capranzano P; Tchetche D; Iadanza A; Sardella G; Van Mieghem NM; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail GW; Sharma S; Ferrer MC; Naber C; Kievit P; Faggioni M; Snyder C; Morice MC; Mehran R;
    JACC Cardiovasc Interv; 2016 Aug; 9(15):1589-600. PubMed ID: 27491609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Value of the SYNTAX Score II in Predicting Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Implantation.
    Ryan N; Nombela-Franco L; Jiménez-Quevedo P; Biagioni C; Salinas P; Aldazábal A; Cerrato E; Gonzalo N; Del Trigo M; Núñez-Gil I; Fernández-Ortiz A; Macaya C; Escaned J
    Rev Esp Cardiol (Engl Ed); 2018 Aug; 71(8):628-637. PubMed ID: 29191780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valve-in-valve transcatheter aortic valve implantation after failed surgically implanted aortic bioprosthesis versus native transcatheter aortic valve implantation for aortic stenosis: Data from a nationwide analysis.
    Deharo P; Bisson A; Herbert J; Lacour T; Saint Etienne C; Jaussaud N; Theron A; Collart F; Bourguignon T; Cuisset T; Fauchier L
    Arch Cardiovasc Dis; 2021 Jan; 114(1):41-50. PubMed ID: 32532695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post procedural risk assessment in patients undergoing trans aortic valve implantation according to the age, creatinine, and ejection fraction-7 score: Advantages of age, creatinine, and ejection fraction-7 in stratification of post-procedural outcome.
    Denegri A; Mehran R; Holy E; Taramasso M; Pasotti E; Pedrazzini G; Moccetti T; Maisano F; Nietlispach F; Obeid S
    Catheter Cardiovasc Interv; 2019 Jan; 93(1):141-148. PubMed ID: 30269398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between valvuloarterial impedance after transcatheter aortic valve implantation and 2-year mortality in elderly patients with severe symptomatic aortic stenosis: the OCEAN-TAVI registry.
    Nagura F; Kataoka A; Hara M; Kozuma K; Watanabe Y; Nakashima M; Hioki H; Kawashima H; Nara Y; Shirai S; Tada N; Araki M; Naganuma T; Yamanaka F; Ueno H; Tabata M; Mizutani K; Higashimori A; Takagi K; Yamamoto M; Hayashida K;
    Heart Vessels; 2019 Jun; 34(6):1031-1039. PubMed ID: 30599060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The predictive value of baseline pulmonary hypertension in early and long term cardiac and all-cause mortality after transcatheter aortic valve implantation for patients with severe aortic valve stenosis: A systematic review and meta-analysis.
    Kokkinidis DG; Papanastasiou CA; Jonnalagadda AK; Oikonomou EK; Theochari CA; Palaiodimos L; Karvounis HI; Armstrong EJ; Faillace RT; Giannakoulas G
    Cardiovasc Revasc Med; 2018; 19(7 Pt B):859-867. PubMed ID: 29724516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The changing characteristics and outcomes of patients undergoing surgical aortic valve replacement in the transcatheter aortic valve implantation era.
    Rozen G; Fefer P; Shinfeld A; Sternik L; Guetta V; Malachy A; Levin S; Feinberg M; Raanani E; Segev A
    J Cardiovasc Med (Hagerstown); 2015 Apr; 16(4):261-6. PubMed ID: 25004001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis.
    Siontis GCM; Overtchouk P; Cahill TJ; Modine T; Prendergast B; Praz F; Pilgrim T; Petrinic T; Nikolakopoulou A; Salanti G; Søndergaard L; Verma S; Jüni P; Windecker S
    Eur Heart J; 2019 Oct; 40(38):3143-3153. PubMed ID: 31329852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial fibrillation before and after transcatheter aortic valve implantation: short- and long-term clinical implications.
    Arrotti S; Sgura FA; Leo G; Vitolo M; Monopoli D; Forzati N; Siena V; Menozzi M; Cataldo P; Stuani M; Morgante V; Magnavacchi P; Gabbieri D; Guiducci V; Benatti G; Vignali L; Rossi R; Boriani G
    J Cardiovasc Med (Hagerstown); 2024 Jan; 25(1):51-59. PubMed ID: 38079281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.